Skip Nav Destination
Issues
Minireviews
Minireview
The Biology Behind
Advances in Brief
Molecular Oncology, Markers, Clinical Correlates
The Granulin-Epithelin Precursor/PC-Cell-derived Growth Factor Is a Growth Factor for Epithelial Ovarian Cancer
Monica Brown Jones; Chad M. Michener; James O. Blanchette; Vladimir A. Kuznetsov; Mark Raffeld; Ginette Serrero; Michael R. Emmert-Buck; Emanuel F. Petricoin; David B. Krizman; Lance A. Liotta; Elise C. Kohn
Hepatocyte Growth Factor Receptor, Matrix Metalloproteinase-11, Tissue Inhibitor of Metalloproteinase-1, and Fibronectin Are Up-Regulated in Papillary Thyroid Carcinoma: A cDNA and Tissue Microarray Study
Veli-Matti Wasenius; Samuli Hemmer; Eeva Kettunen; Sakari Knuutila; Kaarle Franssila; Heikki Joensuu
Regular Articles
Clinical Trials
Repeated Administrations of Interleukin (IL)-12 Are Associated with Persistently Elevated Plasma Levels of IL-10 and Declining IFN-γ, Tumor Necrosis Factor-α, IL-6, and IL-8 Responses
Johanna E. A. Portielje; Cor H. J. Lamers; Wim H. J. Kruit; Alex Sparreboom; Reinder L. H. Bolhuis; Gerrit Stoter; Christoph Huber; Jan W. Gratama
Induction of p53-regulated Genes and Tumor Regression in Lung Cancer Patients after Intratumoral Delivery of Adenoviral p53 (INGN 201) and Radiation Therapy1
Stephen G. Swisher; Jack A. Roth; Ritsuko Komaki; Jian Gu; J. Jack Lee; Marshall Hicks; Jae Y. Ro; Waun K. Hong; James A. Merritt; Kamaran Ahrar; N. Edward Atkinson; Arlene M. Correa; Marcelo Dolormente; Linda Dreiling; Adel K. El-Naggar; Frank Fossella; Rhodette Francisco; Bonnie Glisson; Susan Grammer; Roy Herbst; Armando Huaringa; Bonnie Kemp; Fadlo R. Khuri; Jonathan M. Kurie; Zhongxio Liao; Timothy J. McDonnell; Rudolfo Morice; Frank Morello; Reginald Munden; Vassiliki Papadimitrakopoulou; Katherine M. W. Pisters; Joe B. Putnam, Jr.; Arcenio J. Sarabia; Thomas Shelton; Craig Stevens; Daniel M. Shin; William R. Smythe; Ara A. Vaporciyan; Garrett L. Walsh; Min Yin
Phase I and Pharmacokinetic Study of Escalating Dose of Docetaxel Administered with Granulocyte Colony-stimulating Factor Support in Adult Advanced Solid Tumors
Anthony Gonçalves; Frederic Viret; Joseph Ciccolini; Dominique Genre; Gwenaelle Gravis; Marc Giovanini; Jacques Camerlo; Jacques Catalin; Dominique Maraninchi; Patrice Viens
A Phase I Trial of ISIS 2503, an Antisense Inhibitor of H-ras, in Combination with Gemcitabine in Patients with Advanced Cancer1
Alex A. Adjei; Grace K. Dy; Charles Erlichman; Joel M. Reid; Jeff A. Sloan; Henry C. Pitot; Steven R. Alberts; Richard M. Goldberg; Lorelei J. Hanson; Pamela J. Atherton; Tanya Watanabe; Richard S. Geary; Jon Holmlund; F. Andrew Dorr
A Prospective Randomized Pilot Study to Evaluate Predictors of Response in Serial Core Biopsies to Single Agent Neoadjuvant Doxorubicin or Paclitaxel for Patients with Locally Advanced Breast Cancer1
Vered Stearns; Baljit Singh; Theodore Tsangaris; Jeanette G. Crawford; Antonella Novielli; Mathew J. Ellis; Claudine Isaacs; Marie Pennanen; Cecilia Tibery; Ahmad Farhad; Rebecca Slack; Daniel F. Hayes
European Organization for Research and Treatment of Cancer (EORTC) 08957 Phase II Study of Topotecan in Combination with Cisplatin as Second-Line Treatment of Refractory and Sensitive Small Cell Lung Cancer1
Andrea Ardizzoni; Christian Manegold; Channa Debruyne; Rabab Gaafar; Erika Buchholz; Egbert F. Smit; Pilar Lianes; Guul ten Velde; Lionel Bosquee; Catherine Legrand; Carlo Neumaier; Kathrine King; Giuseppe Giaccone for the EORTC Lung Cancer Group
Cancer Biology, Immunology, Cytokines
Elevated Sod2 Activity Augments Matrix Metalloproteinase Expression: Evidence for the Involvement of Endogenous Hydrogen Peroxide in Regulating Metastasis1
Kristin K. Nelson; Aparna C. Ranganathan; Jelriza Mansouri; Ana M. Rodriguez; Kirwin M. Providence; Joni L. Rutter; Kevin Pumiglia; James A. Bennett; J. Andres Melendez
Research Articles
Molecular Oncology, Markers, Clinical Correlates
Quantitative Polymerase Chain Reaction Monitoring of BCR-ABL during Therapy with Imatinib Mesylate (STI571; Gleevec) in Chronic-Phase Chronic Myelogenous Leukemia
Hagop M. Kantarjian; Moshe Talpaz; Jorge Cortes; Susan O’Brien; Stefan Faderl; Deborah Thomas; Francis Giles; Mary Beth Rios; Jianqin Shan; Ralph Arlinghaus
Expression of the c-Met Proto-Oncogene and Its Possible Involvement in Liver Invasion in Adult T-cell Leukemia1
Yoshitaka Imaizumi; Hiroyuki Murota; Shigeru Kanda; Yoshitaka Hishikawa; Takehiko Koji; Takashi Taguchi; Yuetsu Tanaka; Yasuaki Yamada; Shuichi Ikeda; Tomoko Kohno; Kazuo Yamamoto; Naoki Mori; Masao Tomonaga; Toshifumi Matsuyama
Lymphocyte Recovery in Advanced Ovarian Cancer Patients after High-Dose Chemotherapy and Peripheral Blood Stem Cell Plus Growth Factor Support: Clinical Implications1
Gabriella Ferrandina; Luca Pierelli; Alessandro Perillo; Sergio Rutella; Manuela Ludovisi; Giuseppe Leone; Salvatore Mancuso; Giovanni Scambia
Reduced Expression of the Small Leucine-rich Proteoglycans, Lumican, and Decorin Is Associated with Poor Outcome in Node-negative Invasive Breast Cancer1
Sandra Troup; Catherine Njue; Erich V. Kliewer; Michelle Parisien; Cal Roskelley; Shukti Chakravarti; Peter J. Roughley; Leigh C. Murphy; Peter H. Watson
Quantitative O6-Methylguanine DNA Methyltransferase Methylation Analysis in Curatively Resected Non-Small Cell Lung Cancer: Associations with Clinical Outcome
Jan Brabender; Henning Usadel; Ralf Metzger; Paul M. Schneider; JiMin Park; Dennis Salonga; Denise D. Tsao-Wei; Susan Groshen; Reginald V. Lord; Naoko Takebe; Sylke Schneider; Arnulf H. Hölscher; Kathleen D. Danenberg; Peter V. Danenberg
Hepatocyte Growth Factor and c-Met in Cervical Intraepithelial Neoplasia: Overexpression of Proteins Associated with Oncogenic Human Papillomavirus and Human Immunodeficiency Virus1
Francine Walker; Stéphanie Kermorgant; Emile Daraï; Patrick Madelenat; Anne Claude Cremieux; Dominique Hénin; Thérèse Lehy
Experimental Therapeutics, Preclinical Pharmacology
In Vivo Antitumor Activity of SU11248, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial Growth Factor and Platelet-derived Growth Factor Receptors: Determination of a Pharmacokinetic/Pharmacodynamic Relationship
Dirk B. Mendel; A. Douglas Laird; Xiaohua Xin; Sharianne G. Louie; James G. Christensen; Guangmin Li; Randall E. Schreck; Tinya J. Abrams; Theresa J. Ngai; Leslie B. Lee; Lesley J. Murray; Jeremy Carver; Emily Chan; Katherine G. Moss; Joshua Ö. Haznedar; Juthamas Sukbuntherng; Robert A. Blake; Li Sun; Cho Tang; Todd Miller; Sheri Shirazian; Gerald McMahon; Julie M. Cherrington
Possible Role of Ceramide as an Indicator of Chemoresistance: Decrease of the Ceramide Content via Activation of Glucosylceramide Synthase and Sphingomyelin Synthase in Chemoresistant Leukemia1
Mitsuru Itoh; Toshiyuki Kitano; Mitsumasa Watanabe; Tadakazu Kondo; Takeshi Yabu; Yoshimitu Taguchi; Kazuya Iwai; Masaro Tashima; Takashi Uchiyama; Toshiro Okazaki
Correction
Supplement
Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: Summary Consensus Statement1
Steven E. Come; Aman U. Buzdar; Carlos L. Arteaga; Angela M. Brodie; Nancy E. Davidson; Mitch Dowsett; James N. Ingle; Stephen R. D. Johnston; Adrian V. Lee; C. Kent Osborne; Kathleen I. Pritchard; Victor G. Vogel; Eric P. Winer; Carol S. Hart
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.